By Scott Gottlieb (original source Forbes)
“There’s a growing refrain among those who pay for healthcare services that they want new products to deliver more value. When it comes to prescription drugs, this is usually interpreted to mean medicines that provide more benefit, at lower costs per increment of clinical advantage. Drugs that deliver more bang for the buck.
But pharmaceutical competition usually turns on claims of absolute efficacy rather than the relative and comparative merits of a medicine. There is one obvious reason.
Drug companies can rarely make claims around the value of their medicines.”
Click here to read more
Dr. Sanjay Gupta: Your questions answered as FDA pushes to phase out certain food dyes
The FDA is pushing to phase out petroleum-based food dyes in foods sold in the US. Dr. Sanjay Gupta answers your questions about why Europe,…
Thought Leader: Sanjay Gupta
Dr. Leana Wen: Should you get the shingles vaccine? Answering reader questions.
In addition to protecting against shingles, the vaccine could decrease dementia risk. In light of the worsening measles outbreak, I’ve written several articles emphasizing the…
Thought Leader: Leana Wen
Peter Zeihan: Should the US Stay in the Middle East?
In his latest video recorded in New Zealand, Peter Zeihan, a renowned geopolitical strategist, tackles a key question that shapes U.S. foreign policy: Should the…
Thought Leader: Peter Zeihan
Dr. Sanjay Gupta: Your questions answered as FDA pushes to phase out certain food dyes
Thought Leader: Sanjay Gupta
Dr. Leana Wen: Should you get the shingles vaccine? Answering reader questions.
Thought Leader: Leana Wen
Peter Zeihan: Should the US Stay in the Middle East?
Thought Leader: Peter Zeihan
